Frazier Life Sciences Public Fund, L.P. 13D and 13G filings for Viridian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-08-12 12:35 pm Sale | 2022-08-02 | 13G | Viridian Therapeutics, Inc. VRDN | Frazier Life Sciences Public Fund, L.P. | 300,000 1.100% | -1,205,200 (-80.07%) | Filing |
| 2022-01-28 1:39 pm Purchase | 2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Frazier Life Sciences Public Fund, L.P. | 1,505,200 6.900% | 200,000 (+15.32%) | Filing |
| 2021-08-26 12:56 pm Purchase | 2021-08-16 | 13G | Viridian Therapeutics, Inc. VRDN | Frazier Life Sciences Public Fund, L.P. | 1,305,200 13.600% | 1,305,200 (New Position) | Filing |